跳至主要内容
临床试验/NCT00263731
NCT00263731已完成不适用

Preoperative Metabolomic Analysis of Primary Lung Cancer: A Translational Clinical Trial of the Brown Cancer Center

University of Louisville1 个研究点 分布在 1 个国家目标入组 249 人开始时间: 2005年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
249
试验地点
1
主要终点
metabolic profiles of cancerous vs. healthy lung tissue

研究概览

简要总结

The purpose of this study is to learn more about the metabolic properties of lung cancer cells.

详细描述

It has long been known that cancer cells absorb and break down substances in the body differently than healthy, non-cancer cells. This process of absorbing and breaking down substances is known as metabolism and is increased in cancer cells. Recent research suggests that this increased metabolic activity makes it easier for cancer cells to multiply. The objective of the study is to characterize the metabolism of glucose by lung tumors by serum metabolite analysis, using a variant of glucose (sugar) which makes up 1% of glucose in nature.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with suspected, clinically diagnosed, or histologically diagnosed lung cancer. Occasionally, other cancers (including metastatic cancers to the lung) may be resected for the study as negative controls for NSCLC, as warranted by the particulars of the case.
  • patients must have general medical conditions to allow them to undergo surgical resection of their primary tumor

排除标准

  • history of diabetes for the experimental group (surgery + glucose); patients with a history of diabetes are allowed in the control group (surgery/no glucose)
  • known hepatitis C or HIV (AIDS)
  • Healthy Subjects (Group 3)
  • Inclusion Criteria:
  • at least 30 years of age
  • preferably be fasting for 12 hours (minimum 8 hours) prior to enrollment
  • Exclusion Criteria:
  • prior history of diagnosed lung cancer
  • known hepatitis C or HIV (AIDS)

结局指标

主要结局

metabolic profiles of cancerous vs. healthy lung tissue

时间窗: after 13-C-glucose infusion

次要结局

  • metabolic markers in expired breath(during surgery)
  • glycolytic metabolism in plasma(before and after 13-C-glucose infusion)
  • metabolic markers in urine(collected during surgery)
  • metabolic markers in serum(before and after 13-C-glucose infusion)
  • metabolic markers in bronchoalveolar fluid(during diagnostic bronchoscopy or during surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Donald Miller

Professor

University of Louisville

研究点 (1)

Loading locations...

相似试验

Metabolomic Analysis of Lung Cancer | 临床试验